This chemical is primarily used in the synthesis of pharmaceutical compounds, particularly as an intermediate in the production of active pharmaceutical ingredients (APIs). It plays a key role in the development of drugs targeting specific diseases, including neurological disorders and cancer. Its structure, featuring a tert-butoxycarbonyl (Boc) protecting group, allows for selective reactions in peptide synthesis and other organic transformations. Additionally, it is employed in research settings for the design and optimization of drug candidates, enabling precise modifications to enhance efficacy and reduce side effects.